Third Circuit Court Upholds Decision to Dismiss Pacira BioSciences, Inc. Lawsuit
March 27, 2023 08:00 ET
|
Pacira BioSciences
TAMPA, Fla., March 27, 2023 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX) today announced that the United States Court of Appeals for the Third Circuit affirmed the District Court’s...
Pacira BioSciences Announces Yvonne Greenstreet to Retire from Board of Directors
March 22, 2023 08:00 ET
|
Pacira BioSciences
TAMPA, Fla., March 22, 2023 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to non-opioid pain management and regenerative health solutions, today...
Pacira BioSciences to Participate in Fireside Chat at the 2023 Barclays Global Healthcare Conference
March 08, 2023 08:00 ET
|
Pacira BioSciences
TAMPA, Fla., March 08, 2023 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX) today announced that it will participate in an analyst-led fireside chat at the Barclays Global Healthcare...
Pacira BioSciences Reports Full-Year and Fourth Quarter 2022 Financial Results
February 28, 2023 08:00 ET
|
Pacira BioSciences
— Record revenues of $667 million in 2022 — — Full-year GAAP net income of $16 million and adjusted EBITDA of $213 million — — EXPAREL surpasses the 12 million patient mark — —...
LPGA, Pacira BioSciences Partner to Raise Awareness of Non-Opioid Pain Management Solutions
February 23, 2023 08:00 ET
|
Pacira BioSciences
DAYTONA BEACH, Fla. and TAMPA, Fla., Feb. 23, 2023 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc., (Nasdaq: PCRX), a company committed to non-opioid pain management and regenerative health solutions,...
Pacira to Report 2022 Financial Results on Tuesday February 28, 2023
February 21, 2023 08:00 ET
|
Pacira BioSciences
TAMPA, Fla., Feb. 21, 2023 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ:PCRX) today announced that it will report its fourth quarter and year ended December 31, 2022 financial results before...
Pacira BioSciences Reports Preliminary Unaudited Total Revenue for 2022 of $666.8 Million
January 05, 2023 16:30 ET
|
Pacira BioSciences
TAMPA, Fla., Jan. 05, 2023 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to non-opioid pain management and regenerative health solutions, today...
Pacira BioSciences to Present at the 41st Annual J.P. Morgan Healthcare Conference
January 04, 2023 08:00 ET
|
Pacira BioSciences
TAMPA, Fla., Jan. 04, 2023 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX) today announced that it will present at the 41st Annual J.P. Morgan Healthcare Conference at 3:00 PM PT (6:00PM...
Pacira BioSciences Reports Preliminary Net Product Sales of $57.5 Million for November 2022
December 13, 2022 08:00 ET
|
Pacira BioSciences
TAMPA, Fla., Dec. 13, 2022 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to non-opioid pain management and regenerative health solutions, today...
Pacira BioSciences Reports Preliminary Net Product Sales of $54.9 Million for October 2022
November 14, 2022 08:00 ET
|
Pacira BioSciences
-- EXPAREL average daily sales for October 2022 were 106 percent of October 2021 -- TAMPA, Fla., Nov. 14, 2022 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in...